| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 8 | -404,872 | 100% | $79.79 | -$32,304,469 |
| Net | -8 | -404,872 | -100% | -$32,304,469 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David P. Meeker | President and CEO, Director | $29,698,128 | -$2,837,333 | -8.7% | 11 Feb 2026 |
| Yann Mazabraud | EVP, Head of International | $6,074,447 | -$1,521,444 | -20% | 02 Mar 2026 |
| Pamela J. Cramer | Chief Human Resources Officer | $3,775,890 | -$6,503,690 | -63% | 11 Feb 2026 |
| Jennifer Kayden Lee | EVP, Head of North America | $3,040,334 | 11 Feb 2026 | ||
| Joseph Shulman | Chief Technical Officer | $2,775,638 | -$6,229,323 | -69% | 11 Feb 2026 |
| Alastair Garfield | Chief Scientific Officer | $2,371,002 | -$85,483 | -3.5% | 11 Feb 2026 |
| Hunter C. Smith | Chief Financial Officer | $1,925,910 | -$9,748,524 | -84% | 02 Mar 2026 |
| Mathers Edward T. | Director | $1,762,570 | 02 Mar 2026 | ||
| Linda Shapiro Manning | Chief Medical Officer | $563,250 | 09 Feb 2022 | ||
| Lynn A. Tetrault | Director | $421,260 | 24 Jun 2025 | ||
| David W. J. Mcgirr | Director | $421,260 | -$4,267,494 | -91% | 24 Jun 2025 |
| Jennifer L. Good | Director | $421,260 | 24 Jun 2025 | ||
| Camille L. Bedrosian | Director | $421,260 | 24 Jun 2025 | ||
| Christophe Jean | Director | $421,260 | 24 Jun 2025 | ||
| Stuart A. Arbuckle | Director | $421,260 | 24 Jun 2025 | ||
| William T. Roberts | Chief Accounting Officer | $279,459 | 29 Mar 2023 | ||
| Christopher Paul German | Corporate Controller & CAO | $134,530 | -$1,111,178 | -89% | 04 Mar 2026 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Christopher Paul German | RYTM | Common Stock | Sale | -97.2% | $502,790 | $89.56 | -5,614 | 160 | 04 Mar 2026 | Direct |
| Christopher Paul German | RYTM | Common Stock | Options Exercise | 35.3% | 1,500 | 5,753 | 04 Mar 2026 | Direct | ||
| Christopher Paul German | RYTM | Stock Options (Right to Buy) | Options Exercise | -28.7% | -1,500 | 3,731 | 04 Mar 2026 | Direct | ||
| Yann Mazabraud | RYTM | Stock Options (Right to Buy) | Award | 35,000 | 35,000 | 02 Mar 2026 | Direct | |||
| Mathers Edward T. | RYTM | Common Stock | Other | 72.7% | 4,198 | 9,969 | 02 Mar 2026 | See Note 2 | ||
| Hunter C. Smith | RYTM | Common Stock | Options Exercise | 5.52% | 6,099 | 116,611 | 02 Mar 2026 | Direct | ||
| Hunter C. Smith | RYTM | Stock Options (Right to Buy) | Options Exercise | -6.26% | -6,099 | 91,401 | 02 Mar 2026 | Direct | ||
| Christopher Paul German | RYTM | Common Stock | Tax liability | -7.44% | -342 | 4,253 | 01 Mar 2026 | Direct | ||
| Christopher Paul German | RYTM | Common Stock | Options Exercise | 33.8% | 1,162 | 4,595 | 01 Mar 2026 | Direct | ||
| Christopher Paul German | RYTM | Restricted Stock Units | Options Exercise | -50% | -1,162 | 1,162 | 01 Mar 2026 | Direct | ||
| Hunter C. Smith | RYTM | Common Stock | Sale | -3.82% | $444,004 | $101.26 | -4,385 | 110,512 | 19 Feb 2026 | Direct |
| Hunter C. Smith | RYTM | Common Stock | Sale | -3.01% | $361,810 | $101.38 | -3,569 | 114,897 | 17 Feb 2026 | Direct |
| Yann Mazabraud | RYTM | Common Stock | Options Exercise | 23.2% | 10,000 | 53,155 | 14 Feb 2026 | Direct | ||
| Yann Mazabraud | RYTM | Restricted Stock Units | Options Exercise | -25% | -10,000 | 30,000 | 14 Feb 2026 | Direct | ||
| Hunter C. Smith | RYTM | Common Stock | Sale | -1.33% | $156,380 | $98.23 | -1,592 | 118,466 | 12 Feb 2026 | Direct |
| Joseph Shulman | RYTM | Stock Options (Right to Buy) | Award | 22,500 | 22,500 | 11 Feb 2026 | Direct | |||
| Joseph Shulman | RYTM | Restricted Stock Units | Award | 15,000 | 15,000 | 11 Feb 2026 | Direct | |||
| David P. Meeker | RYTM | Stock Options (Right to Buy) | Award | 107,850 | 107,850 | 11 Feb 2026 | Direct | |||
| David P. Meeker | RYTM | Restricted Stock Units | Award | 71,900 | 71,900 | 11 Feb 2026 | Direct | |||
| Yann Mazabraud | RYTM | Restricted Stock Units | Award | 23,350 | 23,350 | 11 Feb 2026 | Direct | |||
| Jennifer Kayden Lee | RYTM | Stock Options (Right to Buy) | Award | 32,500 | 32,500 | 11 Feb 2026 | Direct | |||
| Jennifer Kayden Lee | RYTM | Restricted Stock Units | Award | 21,650 | 21,650 | 11 Feb 2026 | Direct | |||
| Christopher Paul German | RYTM | Restricted Stock Units | Award | 5,215 | 5,215 | 11 Feb 2026 | Direct | |||
| Alastair Garfield | RYTM | Stock Options (Right to Buy) | Award | 25,000 | 25,000 | 11 Feb 2026 | Direct | |||
| Alastair Garfield | RYTM | Restricted Stock Units | Award | 16,650 | 16,650 | 11 Feb 2026 | Direct | |||
| Pamela J. Cramer | RYTM | Stock Options (Right to Buy) | Award | 17,500 | 17,500 | 11 Feb 2026 | Direct | |||
| Pamela J. Cramer | RYTM | Restricted Stock Units | Award | 11,650 | 11,650 | 11 Feb 2026 | Direct | |||
| Hunter C. Smith | RYTM | Common Stock | Sale | -2.25% | $272,766 | $98.61 | -2,766 | 120,058 | 11 Feb 2026 | Direct |
| Hunter C. Smith | RYTM | Stock Options (Right to Buy) | Award | 37,500 | 37,500 | 11 Feb 2026 | Direct | |||
| Hunter C. Smith | RYTM | Restricted Stock Units | Award | 25,000 | 25,000 | 11 Feb 2026 | Direct | |||
| Hunter C. Smith | RYTM | Common Stock | Sale | -2.16% | $279,429 | $103.00 | -2,713 | 122,824 | 10 Feb 2026 | Direct |
| Hunter C. Smith | RYTM | Common Stock | Sale | -2.62% | $358,599 | $106.06 | -3,381 | 125,537 | 05 Feb 2026 | Direct |
| Hunter C. Smith | RYTM | Common Stock | Sale | -2.46% | $344,145 | $105.99 | -3,247 | 128,918 | 04 Feb 2026 | Direct |
| Yann Mazabraud | RYTM | Common Stock | Options Exercise | 14.6% | 5,500 | 43,155 | 01 Feb 2026 | Direct | ||
| Yann Mazabraud | RYTM | Restricted Stock Units | Options Exercise | -33.3% | -5,500 | 11,000 | 01 Feb 2026 | Direct | ||
| Joseph Shulman | RYTM | Common Stock | Tax liability | -25.5% | -6,507 | 18,970 | 01 Feb 2026 | Direct | ||
| Joseph Shulman | RYTM | Common Stock | Options Exercise | 199.4% | 16,968 | 25,477 | 01 Feb 2026 | Direct | ||
| Joseph Shulman | RYTM | Restricted Stock Units | Options Exercise | -100% | -16,968 | 0 | 01 Feb 2026 | Direct | ||
| Jennifer Kayden Lee | RYTM | Common Stock | Tax liability | -32.4% | -9,237 | 19,233 | 01 Feb 2026 | Direct | ||
| Jennifer Kayden Lee | RYTM | Common Stock | Options Exercise | 386% | 22,612 | 28,470 | 01 Feb 2026 | Direct | ||
| Jennifer Kayden Lee | RYTM | Restricted Stock Units | Options Exercise | -100% | -22,612 | 0 | 01 Feb 2026 | Direct | ||
| Alastair Garfield | RYTM | Common Stock | Tax liability | -20.7% | -2,026 | 7,763 | 01 Feb 2026 | Direct | ||
| Alastair Garfield | RYTM | Common Stock | Options Exercise | 213.2% | 6,663 | 9,789 | 01 Feb 2026 | Direct | ||
| Alastair Garfield | RYTM | Restricted Stock Units | Options Exercise | -25% | -6,663 | 19,987 | 01 Feb 2026 | Direct | ||
| Pamela J. Cramer | RYTM | Common Stock | Tax liability | -13.9% | -4,731 | 29,376 | 01 Feb 2026 | Direct | ||
| Pamela J. Cramer | RYTM | Common Stock | Options Exercise | 63.9% | 13,293 | 34,107 | 01 Feb 2026 | Direct | ||
| Pamela J. Cramer | RYTM | Restricted Stock Units | Options Exercise | -100% | -13,293 | 0 | 01 Feb 2026 | Direct | ||
| Hunter C. Smith | RYTM | Common Stock | Tax liability | -7.52% | -10,750 | 132,165 | 01 Feb 2026 | Direct | ||
| Hunter C. Smith | RYTM | Common Stock | Options Exercise | 22.2% | 26,000 | 142,915 | 01 Feb 2026 | Direct | ||
| Hunter C. Smith | RYTM | Restricted Stock Units | Options Exercise | -100% | -26,000 | 0 | 01 Feb 2026 | Direct |